Hypertension and grading are important risk factors for occult blood loss in hip arthroplasty: a retrospective study analysis

高血压和分级是髋关节置换术后隐性出血的重要危险因素:一项回顾性研究分析

阅读:1

Abstract

OBJECTIVE: To quantify the impact of hypertension and its grading on occult blood loss (HBL) during total hip arthroplasty (THA) and to offer clinical guidance for minimizing HBL. METHODS: Baseline data from femoral neck fracture patients treated with THA between January 2018 and December 2022 were included. SPSS 26.0 statistical software was used for correlation analysis employing statistical methods, including independent samples t-test, Pearson correlation, and multiple linear regression, to identify risk factors for elevated postoperative HBL in THA patients. Hypertension severity was categorized according to international guidelines to investigate the effect of hypertension grading on HBL. RESULTS: The mean perioperative bleeding (TBL) among all patients was 1,123.39 ± 518.89 mL, and the mean HBL was 923.93 ± 489.04 mL, which accounted for 78.76% ± 16.09% of the TBL. HBL was significantly higher in hypertensive patients (957.98 ± 509.72 mL vs. 895.94 ± 469.97 mL, P = 0.042). Multiple linear regression analysis revealed that hypertension was an independent predictor of HBL (P = 0.030). Grade 2 hypertension increased HBL by 11.2% (996.46 ± 573.80 mL, P = 0.046), while grade 3 hypertension further increased HBL by 18.7% (1,063.76 ± 584.11 mL, P = 0.044). Hypoalbuminemia had a clinically relevant, but not statistically significant, synergistic effect with hypertension (ΔHBL = 119.60 mL, P = 0.297). CONCLUSION: Hypertension ≥ grade 2 (systolic blood pressure ≥ 160 mmHg) independently exacerbates HBL in THA patients through a dose-response relationship. It is recommended that preoperative systolic blood pressure be maintained below 160 mmHg, and metabolic status be optimized to reduce the risk of blood transfusion.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。